- Home
- LIDR vs RPTX Comparison
LIDR vs RPTX Comparison
Compare LIDR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- RPTX
- Stock Information
- Founded
- LIDR 2013
- RPTX 2016
- Country
- LIDR United States
- RPTX Canada
- Employees
- LIDR N/A
- RPTX N/A
- Industry
- LIDR Auto Parts:O.E.M.
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- RPTX Health Care
- Exchange
- LIDR Nasdaq
- RPTX Nasdaq
- Market Cap
- LIDR 105.4M
- RPTX 92.4M
- IPO Year
- LIDR N/A
- RPTX 2020
- Fundamental
- Price
- LIDR $2.43
- RPTX $2.13
- Analyst Decision
- LIDR Strong Buy
- RPTX Strong Buy
- Analyst Count
- LIDR 1
- RPTX 3
- Target Price
- LIDR $6.00
- RPTX $3.50
- AVG Volume (30 Days)
- LIDR 2.1M
- RPTX 1.1M
- Earning Date
- LIDR 11-06-2025
- RPTX 11-14-2025
- Dividend Yield
- LIDR N/A
- RPTX N/A
- EPS Growth
- LIDR N/A
- RPTX N/A
- EPS
- LIDR N/A
- RPTX N/A
- Revenue
- LIDR $182,000.00
- RPTX $11,870,000.00
- Revenue This Year
- LIDR $1.50
- RPTX N/A
- Revenue Next Year
- LIDR $2,806.06
- RPTX N/A
- P/E Ratio
- LIDR N/A
- RPTX N/A
- Revenue Growth
- LIDR N/A
- RPTX N/A
- 52 Week Low
- LIDR $0.49
- RPTX $0.89
- 52 Week High
- LIDR $6.44
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- LIDR 47.69
- RPTX 64.44
- Support Level
- LIDR $2.28
- RPTX $2.08
- Resistance Level
- LIDR $2.54
- RPTX $2.30
- Average True Range (ATR)
- LIDR 0.20
- RPTX 0.08
- MACD
- LIDR 0.01
- RPTX 0.04
- Stochastic Oscillator
- LIDR 63.21
- RPTX 73.08
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.